There is no correlation between high-density lipoprotein cholesterol (HDL-C) levels and a patient's risk for developing ...

A significant breakthrough in the understanding of sleep mechanism opens new promise for treating sleep disorders and associated neuropsychiatric conditions: Scientists have pinpointed the melatonin ...

Parkinson's comes on slowly, and diagnosing the often-devastating movement disorder, particularly in its early stages, ...

There is no correlation between high-density lipoprotein cholesterol (HDL-C) levels and a patient's risk for developing ...

Scientists have identified the melatonin MT1 receptor as a key regulator of REM sleep, crucial for memory, dreaming, and ...

A significant breakthrough in the understanding of sleep mechanism opens new promise for treating sleep disorders and associated neuropsychiatric conditions: Scientists have pinpointed the melatonin ...

Johns Hopkins launches OneNeuro, a cross-disciplinary initiative to utilize emerging technologies and AI to finally crack the code on the enigmatic human brain ...

Exercise is known as one of the best weapons in limiting the effects of the disease and creating dopamine that is low for ...

Movement disorders are a group of neurological syndromes in which the hallmark symptom is paucity of movement, excessive and/or involuntary movement or tremor. Movement disorders can be ...

Analyst Jason McCarthy from Maxim Group reiterated a Buy rating on Gain Therapeutics (GANX – Research Report) and keeping the price ...

Researchers are studying how leukocyte telomere length may be associated with the progression of Friedreich's ataxia.

With fresh, positive data in hand, Biohaven now believes its medicine could be the first to receive FDA approval for spinocerebellar ataxia.